Mutant PIK3CA promotes cell growth and invasion of human cancer cells
- PMID: 15950905
- DOI: 10.1016/j.ccr.2005.05.014
Mutant PIK3CA promotes cell growth and invasion of human cancer cells
Abstract
PIK3CA is mutated in diverse human cancers, but the functional effects of these mutations have not been defined. To evaluate the consequences of PIK3CA alterations, the two most common mutations were inactivated by gene targeting in colorectal cancer (CRC) cells. Biochemical analyses of these cells showed that mutant PIK3CA selectively regulated the phosphorylation of AKT and the forkhead transcription factors FKHR and FKHRL1. PIK3CA mutations had little effect on growth under standard conditions, but reduced cellular dependence on growth factors. PIK3CA mutations resulted in attenuation of apoptosis and facilitated tumor invasion. Treatment with the PI3K inhibitor LY294002 abrogated PIK3CA signaling and preferentially inhibited growth of PIK3CA mutant cells. These data have important implications for therapy of cancers harboring PIK3CA alterations.
Similar articles
-
Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells.Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):294-300. doi: 10.1161/01.ATV.0000110502.10593.06. Epub 2003 Dec 1. Arterioscler Thromb Vasc Biol. 2004. PMID: 14656735
-
Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a).Mol Cell Biol. 2001 Feb;21(3):952-65. doi: 10.1128/MCB.21.3.952-965.2001. Mol Cell Biol. 2001. PMID: 11154281 Free PMC article.
-
Phosphorylation and nuclear exclusion of the forkhead transcription factor FKHR after epidermal growth factor treatment in human breast cancer cells.Oncogene. 2000 Sep 21;19(40):4574-81. doi: 10.1038/sj.onc.1203825. Oncogene. 2000. PMID: 11030146
-
Transcriptional regulation of neuronal genes and its effect on neural functions: expression and function of forkhead transcription factors in neurons.J Pharmacol Sci. 2005 Jul;98(3):205-11. doi: 10.1254/jphs.fmj05001x3. Epub 2005 Jul 9. J Pharmacol Sci. 2005. PMID: 16006742 Review.
-
FOXO transcription factors in cancer development and therapy.Cell Mol Life Sci. 2016 Mar;73(6):1159-72. doi: 10.1007/s00018-015-2112-y. Epub 2015 Dec 19. Cell Mol Life Sci. 2016. PMID: 26686861 Free PMC article. Review.
Cited by
-
The latest therapeutic strategies after resistance to first generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) in patients with non-small cell lung cancer (NSCLC).Ann Transl Med. 2015 May;3(7):96. doi: 10.3978/j.issn.2305-5839.2015.03.60. Ann Transl Med. 2015. PMID: 26015938 Free PMC article. Review.
-
PI3K-targeting strategy using alpelisib to enhance the antitumor effect of paclitaxel in human gastric cancer.Sci Rep. 2020 Jul 23;10(1):12308. doi: 10.1038/s41598-020-68998-w. Sci Rep. 2020. PMID: 32704014 Free PMC article.
-
Phosphatidyl inositol-3 kinase (PIK3CA) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells.Oncotarget. 2016 Dec 13;7(50):82424-82439. doi: 10.18632/oncotarget.10955. Oncotarget. 2016. PMID: 27489350 Free PMC article.
-
Pro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy.Future Oncol. 2010 Apr;6(4):587-603. doi: 10.2217/fon.10.15. Future Oncol. 2010. PMID: 20373871 Free PMC article. Review.
-
Activating mutations in TOR are in similar structures as oncogenic mutations in PI3KCalpha.ACS Chem Biol. 2009 Dec 18;4(12):999-1015. doi: 10.1021/cb900193e. ACS Chem Biol. 2009. PMID: 19902965 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous